US2011183924A1PendingUtilityA1

Methods and systems for annotating biomolecular sequences

43
Assignee: COMPUGEN LTDPriority: Sep 14, 2001Filed: Apr 23, 2010Published: Jul 28, 2011
Est. expirySep 14, 2021(expired)· nominal 20-yr term from priority
A61P 37/00A61P 35/00G16B 20/00A61P 29/00G16B 40/00A61P 31/00G16B 30/00G16B 30/10G16B 30/20G16B 40/30G16B 40/10
43
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A method of annotating biomolecular sequences. The method comprises (a) computationally clustering the biomolecular sequences according to a progressive homology range, to thereby generate a plurality of clusters each being of a predetermined homology of the homology range; and (b) assigning at least one ontology to each cluster of the plurality of clusters, the at least one ontology being: (i) derived from an annotation preassociated with at least one biomolecular sequence of each cluster; and/or (ii) generated from analysis of the at least one biomolecular sequence of each cluster thereby annotating biomolecular sequences.

Claims

exact text as granted — not AI-modified
1 . An isolated protein having the sequence according to the amino acid sequence of any of SEQ ID NOs: 35-38, 737437-1034311. 
     
     
         2 . An isolated polynucleotide, consisting of a nucleic acid sequence encoding the amino acid sequence of the protein of  claim 1 . 
     
     
         3 . A pharmaceutical composition comprising an isolated protein having the sequence according to the amino acid sequence of any of SEQ ID NOs: 35-38, 737437-1034311, and a pharmaceutically acceptable carrier.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.